NewEdge Wealth LLC Invests $244,000 in STERIS plc (NYSE:STE)

NewEdge Wealth LLC purchased a new position in shares of STERIS plc (NYSE:STEFree Report) during the 4th quarter, HoldingsChannel reports. The institutional investor purchased 1,108 shares of the medical equipment provider’s stock, valued at approximately $244,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in STE. Millburn Ridgefield Corp acquired a new position in STERIS during the 3rd quarter worth about $25,000. Catalyst Capital Advisors LLC acquired a new position in STERIS during the 3rd quarter worth about $25,000. 1832 Asset Management L.P. acquired a new position in STERIS during the 1st quarter worth about $25,000. Global Wealth Management Investment Advisory Inc. acquired a new position in STERIS during the 3rd quarter valued at about $49,000. Finally, NBC Securities Inc. acquired a new position in STERIS during the 3rd quarter valued at about $50,000. Institutional investors and hedge funds own 94.69% of the company’s stock.

STERIS Stock Performance

Shares of STE stock opened at $200.71 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.49 and a current ratio of 2.43. The company has a market capitalization of $19.83 billion, a P/E ratio of 35.15 and a beta of 0.79. The company’s 50 day moving average price is $224.20 and its two-hundred day moving average price is $217.59. STERIS plc has a 52 week low of $180.54 and a 52 week high of $254.00.

STERIS (NYSE:STEGet Free Report) last announced its earnings results on Wednesday, February 7th. The medical equipment provider reported $2.22 EPS for the quarter, topping the consensus estimate of $2.17 by $0.05. The firm had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.35 billion. STERIS had a net margin of 10.48% and a return on equity of 13.67%. The business’s quarterly revenue was up 14.8% on a year-over-year basis. During the same period last year, the company posted $2.02 EPS. On average, analysts expect that STERIS plc will post 8.67 earnings per share for the current fiscal year.

STERIS Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 22nd. Shareholders of record on Friday, February 23rd were issued a dividend of $0.52 per share. The ex-dividend date was Thursday, February 22nd. This represents a $2.08 annualized dividend and a yield of 1.04%. STERIS’s dividend payout ratio (DPR) is currently 36.43%.

Wall Street Analyst Weigh In

A number of research analysts have issued reports on the stock. Stephens restated an “overweight” rating and set a $250.00 target price on shares of STERIS in a research report on Friday, February 9th. JMP Securities reissued a “market outperform” rating and set a $265.00 price objective on shares of STERIS in a research note on Thursday, February 8th. Needham & Company LLC reissued a “hold” rating on shares of STERIS in a research note on Friday, April 12th. TheStreet raised shares of STERIS from a “c+” rating to a “b” rating in a research note on Wednesday, February 7th. Finally, KeyCorp assumed coverage on shares of STERIS in a research note on Tuesday, February 6th. They set an “overweight” rating and a $253.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, STERIS presently has a consensus rating of “Moderate Buy” and a consensus target price of $239.60.

Read Our Latest Stock Analysis on STERIS

About STERIS

(Free Report)

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.

Further Reading

Want to see what other hedge funds are holding STE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for STERIS plc (NYSE:STEFree Report).

Institutional Ownership by Quarter for STERIS (NYSE:STE)

Receive News & Ratings for STERIS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS and related companies with MarketBeat.com's FREE daily email newsletter.